211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- Myelodysplastic Syndrome With Excess Blasts
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Lymphoblastic Leukemia
- Recurrent Acute Lymphoblastic Leukemia
- Recurrent Mixed Phenotype Acute Leukemia
- Refractory Acute Myeloid Leukemia
- Refractory Mixed Phenotype Acute Leukemia
- Mixed Phenotype Acute Leukemia
Interventions
- DRUG: Cyclosporine
- DRUG: Fludarabine Phosphate
- DRUG: Mycophenolate Mofetil
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- RADIATION: Pretargeted Radioimmunotherapy
- RADIATION: Total-Body Irradiation
- RADIATION: Pretargeted Radioimmunotherapy
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Single Photon Emission Computed Tomography
Sponsor
Fred Hutchinson Cancer Center
Collaborators